CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas

被引：3

作者：

不详

机构：

[1] Institut National de la Santé et de la Recherche Médicale (INSERM) U1160, Institut de Recherche Saint-Louis, Paris

[2] Université Paris Cité, Institut de Recherche Saint-Louis, Paris

[3] Pathology Department, Saint-Louis Hospital, Assistance Publique–Hôpitaux de Paris, Paris

[4] Institut National de la Santé et de la Recherche Médicale (INSERM) U976 HIPI, Institut de Recherche Saint-Louis, Paris

[5] Department of Dermatology, Charité Hospital, Berlin

[6] Department of Dermatology, Saint-Louis Hospital, Assistance Publique–Hôpitaux de Paris, Paris

[7] Pharmacy, Saint-Louis Hospital, Assistance Publique–Hôpitaux de Paris, Paris

[8] Department of Hematology, Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Clermont-Ferrand

[9] Department of Dermatology, Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Clermont-Ferrand

[10] Hematology Laboratory, Centre Hospitalier Universitaire (CHU) Clermont-Ferrand, Clermont-Ferrand

[11] Hematology Laboratory, Saint-Louis Hospital, Assistance Publique–Hôpitaux de Paris, Paris

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 07期

关键词：

D O I：

10.1016/j.jid.2023.01.009

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：1329 / +

页数：6

共 12 条

[1] CD38 LIGATION INDUCES DISCRETE CYTOKINE MESSENGER-RNA EXPRESSION IN HUMAN CULTURED LYMPHOCYTES
AUSIELLO, CM
URBANI, F
LASALA, A
FUNARO, A
MALAVASI, F
[J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) : 1477 - 1480
[2] Lenalidomide enhances MOR202-dependent macrophage -mediated effector functions via the vitamin D pathway
Busch, Leonhard
Mougiakakos, Dimitrios
Buettner-Herold, Maike
Mueller, Miriam J.
Volmer, Dietrich A.
Bach, Christian
Fabri, Mario
Bittenbring, Joerg T.
Neumann, Frank
Boxhammer, Rainer
Nolting, Jens
Bisht, Savita
Boettcher, Martin
Jitschin, Simon
Hoffmann, Markus H.
Balzer, Heidi
Beier, Fabian
Gezer, Deniz
Dudziak, Diana
Gelse, Kolja
Hennig, Friedrich F.
Pallasch, Christian P.
Spriewald, Bernd
Mackensen, Andreas
Bruns, Heiko
[J]. LEUKEMIA, 2018, 32 (11) : 2445 - 2458
[3] Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma
Feng, Xiaoyan
Zhang, Li
Acharya, Chirag
An, Gang
Wen, Kenneth
Qiu, Lugui
Munshi, Nikhil C.
Tai, Yu-Tzu
Anderson, Kenneth C.
[J]. CLINICAL CANCER RESEARCH, 2017, 23 (15) : 4290 - 4300
[4] Therapeutic Potential and Role of CD38 in Cutaneous T-Cell Lymphoma Pathogenesis
Isabelle, Colleen
McConnell, Kathleen
Boles, Amy E.
Brammer, Jonathan E.
Berge, Robyn
Portocarrero, Carla
Chakravarti, Nitin
Porcu, Pierluigi
Nikbakht, Neda
Mishra, Anjali
[J]. BLOOD, 2022, 140 : 9216 - 9218
[5] Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sezary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project
Kim, Youn H.
Tavallaee, Mahkam
Sundram, Uma
Salva, Katrin A.
Wood, Gary S.
Li, Shufeng
Rozati, Sima
Nagpal, Seema
Krathen, Michael
Reddy, Sunil
Hoppe, Richard T.
Nguyen-Lin, Annie
Weng, Wen-Kai
Armstrong, Randall
Pulitzer, Melissa
Advani, Ranjana H.
Horwitz, Steven M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) : 3750 - +
[6] Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
Krejcik, Jakub
Casneuf, Tineke
Nijhof, Inger S.
Verbist, Bie
Bald, Jaime
Plesner, Torben
Syed, Khaja
Liu, Kevin
van de Donk, Niels W. C. J.
Weiss, Brendan M.
Ahmadi, Tahamtan
Lokhorst, Henk M.
Mutis, Tuna
Sasser, A. Kate
[J]. BLOOD, 2016, 128 (03) : 384 - 394
[7] Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
Lokhorst, H. M.
Plesner, T.
Laubach, J. P.
Nahi, H.
Gimsing, P.
Hansson, M.
Minnema, M. C.
Lassen, U.
Krejcik, J.
Palumbo, A.
van de Donk, N. W. C. J.
Ahmadi, T.
Khan, I.
Uhlar, C. M.
Wang, J.
Sasser, A. K.
Losic, N.
Lisby, S.
Basse, L.
Brun, N.
Richardson, P. G.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13) : 1207 - 1219
[8] A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma
Martin, Thomas
Baz, Rachid
Benson, Don M.
Lendvai, Nikoletta
Wolf, Jeffrey
Munster, Pamela
Lesokhin, Alexander M.
Wack, Claudine
Charpentier, Eric
Campana, Frank
Vij, Ravi
[J]. BLOOD, 2017, 129 (25) : 3294 - 3303
[9] Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
Olsen, Elise A.
Whittaker, Sean
Willemze, Rein
Pinter-Brown, Lauren
Foss, Francine
Geskin, Larisa
Schwartz, Lawrence
Horwitz, Steven
Guitart, Joan
Zic, John
Kim, Youn H.
Wood, Gary S.
Duvic, Madeleine
Ai, Wei
Girardi, Michael
Gru, Alejandro
Guenova, Emmanuella
Hodak, Emmilia
Hoppe, Richard
Kempf, Werner
Kim, Ellen
Lechowicz, Mary Jo
Ortiz-Romero, Pablo
Papadavid, Evangelia
Quaglino, Pietro
Pittelkow, Mark
Prince, H. Miles
Sanches, Jose Antonio
Sugaya, Makoto
Vermeer, Maarten
Zain, Jasmine
Knobler, Robert
Stadler, Rudolf
Bagot, Martine
Scarisbrick, Julia
[J]. BLOOD, 2022, 140 (05) : 419 - 437
[10] CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study
Quaglino, Pietro
Novelli, Mauro
Fava, Paolo
Ortolan, Erika
Astrua, Chiara
Tonella, Luca
Tomasini, Carlo Francesco
Senetta, Rebecca
Ribero, Simone
Ponti, Renata
Fierro, Maria Teresa
Funaro, Ada
[J]. DISEASE MARKERS, 2022, 2022

← 1 2 →